Biomatter raises $18M series a

◆ Amount

$18M

◆ Announced

12 Nov 2026

◆ Company

◆ Source

◆ The Round

Biomatter raised $18M in series a funding, announced on 12 November 2026, led by Astanor, with participation from UVC Partners, Inventure, Metaplanet. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Biomatter

AI-powered enzyme design company that creates custom enzymes for biopharma, diagnostics, agriculture and industrial biotech applications. Biomatter is based in Lithuania and currently at series a stage, operating in Biotech.

◆ Investors

◆ Investing funds on Raise

• UVC Partners
• Metaplanet

◆ Market context

UVC Partners and Metaplanet are profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links Biomatter's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market